Life Sciences Marketing Agency or Market Engineering Practice and Which One Pre-Traction Medtech Founders Need

Key Takeaways

• A life sciences marketing agency runs campaigns and produces content. A market engineering practice builds the market those campaigns need to work.
• Most medtech startups fail because the market never forms around them, not because the product fails. A life sciences marketing agency cannot fix a market that was never built.
• Campaigns without a defined category don't generate demand. They generate noise in a market that doesn't yet know it needs your device.
• Market engineering precedes marketing execution in every major medtech exit: category design, narrative construction, and minimum viable category come before campaigns at scale.
• Bruce Cleveland argues that medtech faces a two-phase commercial problem, FDA clearance and market clearance, and few companies do the work required for the second phase.
• The right time to hire a life sciences marketing agency is after the category is defined, the narrative is clear, and early clinical adoption has validated the pull signal.

A life sciences marketing agency produces campaigns. Market engineering builds the market those campaigns need to exist. These are not the same job, and most pre-traction medtech founders hire the first one when they need the second.

Watch the full episode on YouTube

Why Most Life Sciences Marketing Fails Before It Starts

I'll say something uncomfortable. Most life sciences marketing fails before a single campaign goes live.

The failure doesn't show up in the agency's work. The creative is often good. The content is often competent. The media placements are fine.

The failure is structural. Marketing campaigns are designed to capture demand. In most pre-traction medtech companies, there is no demand to capture.

There are a handful of curious early adopters and a market that hasn't yet formed a shared understanding of the problem, the category, or the clinical criteria for evaluation.

I covered the root cause directly on an episode about what MVM Partners looks for in medtech companies:

"Most medtech startups don't fail because of product. A lot of them fail because the market never really formed around them."

A life sciences marketing agency can amplify a signal. It cannot create one. If the signal doesn't exist, if clinicians can't articulate the problem in your language, if hospital buyers don't have a category framework for evaluating your device, the campaign will generate impressions and nothing else.

This is why life sciences marketing budgets disappear without results so reliably at the pre-traction stage. The inputs drive the failure.

What Market Engineering Does That Life Sciences Marketing Cannot

Market engineering and life sciences marketing are complements. The problem is sequence.

Most pre-traction founders hire the agency first. The more important step, engineering the market the agency will eventually address, gets skipped or conflated with the agency's job.

Bruce Cleveland, who has backed some of the most successful medtech and SaaS companies, described the two-phase medtech problem on an episode about the truth about product-market fit and category design:

"There's always a two-phase problem with med devices. First there's the FDA. And you've got to clear the market. It's very expensive to do that, and few do the work. Which is rather shocking because I think research is fundamental to science."

The first phase is regulatory. The second phase is commercial market clearance, getting the market to understand the category, adopt the language, and develop the evaluation criteria that put your device in the right frame.

A life sciences marketing agency serves the second phase well, but only after the work is done. Category design, narrative architecture, minimum viable category, these come before the campaigns.

When you run campaigns before the market is engineered, you're asking buyers to evaluate a product in a category they don't recognize, against criteria they haven't adopted. The result is low conversion, high educational burden, and a pipeline that stalls at the same stage every time.

What the Technology Adoption Curve Says About Life Sciences Marketing Timing

Early adopters don't respond to marketing campaigns. They respond to vision.

I covered this dynamic on an episode about technology adoption and crossing the chasm:

"Early adopters, they buy possibility. Early majority, they buy category clarity."

The practical implication: life sciences marketing campaigns are designed for the early majority. They use evidence, case studies, and social proof to convert pragmatic buyers who need to see peer validation before committing.

But pre-traction medtech companies are in the early adopter phase. Their buyers don't need campaigns. They need a compelling category narrative and direct access to someone who can articulate why the world is different now that this device exists.

Running a full campaign infrastructure before reaching minimum viable category is the wrong sequence.

"A lot of companies reach early traction but very few make it to mainstream adoption. The failure point is the chasm. Early traction doesn't guarantee scale."

Market engineering is the work that closes that chasm. Life sciences marketing is the amplification that follows it.

What MarketCraft Does Differently

MarketCraft is not a life sciences marketing agency. It's a market engineering practice.

The distinction shows up in what the engagement produces. A life sciences marketing agency delivers content, campaigns, and media placements. A market engineering practice delivers a category narrative, a belief system for clinical adoption, and the commercial infrastructure that makes every subsequent marketing investment more efficient.

The work at MarketCraft starts before any campaign goes live. Category design. Narrative architecture. Minimum viable category validation. Early clinical adopter identification and engagement.

The point is to build the market so that when marketing campaigns run, they land in a market that already has a shared language for the problem.

I described the MarketCraft approach at the MD&M West keynote earlier this year:

"We focus on engineering markets. We use AI-trained models, psychology, persuasion, and strategic storytelling to manufacture something that every single CEO needs: leverage. Leverage with the market, leverage with investors, leverage with strategics."

That's the difference between market engineering and campaign execution. One creates leverage. The other spends it.

For the full commercialization framework, read why 4 in 5 medtech companies fail after FDA clearance despite clinical validation. The pattern is consistent. The companies that built durable commercial engines did the market engineering work first.

When to Hire a Life Sciences Marketing Agency

The right time to hire a life sciences marketing agency is after the market engineering is done.

Specifically: after the category narrative is defined and tested, after minimum viable category has been achieved (stakeholders are describing the problem in your language without your help), and after early clinical adoption has begun to create a reference base.

At that point, a life sciences marketing agency can amplify what already exists. Content can reach buyers who are already predisposed to the category. Case studies land because the evaluative framework is in place. Campaigns produce pipeline because the market already understands why it needs the solution.

The sequence matters more than the spend level. A large life sciences marketing budget deployed before the market engineering is done will underperform a smaller budget deployed after. This is why many medtech companies burn through marketing agencies without results, they hired the right partner at the wrong stage.

Read how category design in medtech creates the conditions that make marketing campaigns productive. Category first, campaigns second. Every time.

What This Means for Pre-Traction Founders

Pre-traction medtech founders face a specific pressure: the board wants to see commercial momentum, and hiring a life sciences marketing agency is the most legible signal of commercial intent.

The problem is that legibility and effectiveness are different things. Paying a life sciences marketing agency to run campaigns before the category is defined is legible. It looks like commercial investment. It rarely produces commercial results.

The questions worth asking before any agency engagement: Can a clinician in your target market describe the problem you solve in your language without coaching?

Are deals stalling at the same stage, or at random stages? Is the message resonating consistently, or does every conversation require rebuilding the category from scratch?

If the answers are mostly no, the next step is market engineering, not marketing execution. The agency comes after.

Frequently Asked Questions

What Does a Life Sciences Marketing Agency Do?

A life sciences marketing agency provides marketing services to companies in pharma, biotech, and medical devices. Services typically include content marketing, digital campaigns, SEO, social media, email marketing, and event presence.

The better agencies understand the regulatory environment and clinical buyer psychology in regulated industries. What most life sciences marketing agencies do not do is market engineering: category design, narrative architecture, and minimum viable category development.

When Should a Medtech Company Hire a Life Sciences Marketing Agency?

A medtech company should hire a life sciences marketing agency after the market engineering phase is complete.

This means after the category narrative is defined, after minimum viable category has been achieved (stakeholders describe the problem in your language without coaching), and after early clinical adoption has begun to create a reference base. Hiring before this point produces campaigns that can't convert because the evaluative framework is not yet in place.

What Is Market Engineering in Medtech?

Market engineering in medtech is the practice of designing the market before selling into it. It involves category design, narrative construction, minimum viable category development, and early clinical adopter engagement.

The goal is to shape how the market understands the problem, evaluates solutions, and develops the language that makes subsequent marketing campaigns productive. MarketCraft is a market engineering practice purpose-built for early-stage medtech companies.

What Is the Difference Between a Life Sciences Marketing Agency and a Market Engineering Practice?

A life sciences marketing agency runs campaigns, produces content, and manages media placements to capture existing demand. A market engineering practice builds the demand infrastructure that makes campaigns worth running.

The key difference is sequence: market engineering comes before campaign execution, not alongside it. Pre-traction medtech companies need market engineering. Post-traction medtech companies benefit from both.

Listen to the Full Episode

Omar's full breakdown of market engineering versus life sciences marketing is available on The State of MedTech. Watch on YouTube. Subscribe wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.

He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.